Dysbiosis contributes to fibrogenesis in the course of chronic liver injury in mice.
about
Diet, Microbiota, Obesity, and NAFLD: A Dangerous QuartetMolecular prognostic prediction in liver cirrhosisGut-liver axis in liver cirrhosis: How to manage leaky gut and endotoxemiaContributions of metabolic dysregulation and inflammation to nonalcoholic steatohepatitis, hepatic fibrosis, and cancerGut Microbiota and Host Reaction in Liver DiseasesNorovirus Regulation by Host and Microbe.Cirrhosis and dysbiosis: New insights from next-generation sequencing.The Angiogenesis Inhibitor ALS-L1023 from Lemon-Balm Leaves Attenuates High-Fat Diet-Induced Nonalcoholic Fatty Liver Disease through Regulating the Visceral Adipose-Tissue Function.Cardiac function in patients with early cirrhosis during maximal beta-adrenergic drive: a dobutamine stress study.Bile acid dysregulation, gut dysbiosis, and gastrointestinal cancer.Pathobiology of liver fibrosis: a translational success storyNatural killer T cells play a necessary role in modulating of immune-mediated liver injury by gut microbiota.Reduction of endotoxin attenuates liver fibrosis through suppression of hepatic stellate cell activation and remission of intestinal permeability in a rat non-alcoholic steatohepatitis model.Implication of gut microbiota in nonalcoholic fatty liver disease.Meta-omic platforms to assist in the understanding of NAFLD gut microbiota alterations: tools and applications.HCC development is associated to peripheral insulin resistance in a mouse model of NASH.Hepatic inflammation and fibrosis: functional links and key pathways.Intestinal transport and metabolism of bile acidsCommensal microbiota is hepatoprotective and prevents liver fibrosis in miceThe gut microbiota of nonalcoholic fatty liver disease: current methods and their interpretationThe gut microbiota and liver disease.PATHOGENESIS OF HEPATOCELLULAR CARCINOMA DEVELOPMENT IN NON ALCOHOLIC FATTY LIVER DISEASEThe severity of nonalcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiotaTCDD modulation of gut microbiome correlated with liver and immune toxicity in streptozotocin (STZ)-induced hyperglycemic mice.Gut microbiota are linked to increased susceptibility to hepatic steatosis in low-aerobic-capacity rats fed an acute high-fat dietAn Intestinal Microbiota-Farnesoid X Receptor Axis Modulates Metabolic Disease.Pro-Inflammatory Cytokines but Not Endotoxin-Related Parameters Associate with Disease Severity in Patients with NAFLDLPS-induced TNF-α factor mediates pro-inflammatory and pro-fibrogenic pattern in non-alcoholic fatty liver diseaseProsteatotic and Protective Components in a Unique Model of Fatty Liver: Gut Microbiota and Suppressed Complement SystemAltered Fecal Microbiota Correlates with Liver Biochemistry in Nonobese Patients with Non-alcoholic Fatty Liver Disease.Bacterial translocation aggravates CCl4-induced liver cirrhosis by regulating CD4+ T cells in ratsGut-liver axis in alcoholic liver diseaseRecent advancement of molecular mechanisms of liver fibrosis.Nonalcoholic fatty liver disease and type 2 diabetes: common pathophysiologic mechanisms.Western Diet-Induced Dysbiosis in Farnesoid X Receptor Knockout Mice Causes Persistent Hepatic Inflammation after Antibiotic Treatment.Gut Microbiota of Nonalcoholic Fatty Liver Disease.Modulation of the gut microbiota impacts nonalcoholic fatty liver disease: a potential role for bile acids.Gut Microbiome-Based Metagenomic Signature for Non-invasive Detection of Advanced Fibrosis in Human Nonalcoholic Fatty Liver Disease.Endoplasmic reticulum stress-induced hepatic stellate cell apoptosis through calcium-mediated JNK/P38 MAPK and Calpain/Caspase-12 pathways.Dietary sphingolipids: potential for management of dyslipidemia and nonalcoholic fatty liver disease.
P2860
Q26752614-6810BFEB-57A2-4E4C-9208-15D7939E2248Q26784251-FB85A89A-93AA-4808-B242-7AEC9F5BDC14Q26826919-878D22F5-2220-44F2-9A90-9A58F6ABC8A9Q26992106-CEA39F2A-423E-409A-8A59-A0ACE64EE999Q28083295-5D14542C-EDE5-4231-B888-3AF3981DD3E1Q30240631-03AF08A1-FF16-404F-8CA8-0708ABFBB449Q30278800-DC854348-1259-4D4D-AEC2-69DADD3120B8Q33624836-497F735B-075D-486C-AA96-A7C23255FD49Q34287422-E90B183E-B897-44E2-AF3C-73B28301EEA5Q34425909-6F85119F-EF75-436D-9DE0-46D9BBBBA169Q34462733-5CB61D6F-B5AA-49E7-B840-BEBB59208358Q34590195-36A657EF-F652-4FC1-B38B-853B66E97422Q34731373-9266D487-08AD-420D-976C-7B6627F6097BQ35019282-0B3A3683-3152-4503-958E-DEAC8E66C139Q35084719-43883962-F88C-4728-9312-3F2E74DA7DC6Q35172679-A382EF04-6169-42E2-B24F-D52D4C9DD706Q35213917-F56E6B45-54DE-465E-ACFD-4D114B8D2361Q35247159-466FACC2-ADC5-4584-A13D-53ABBB09176AQ35481673-13335882-9B42-424C-96A5-36C7568086AFQ35661635-28B9EB8C-19A9-4AE4-BC05-53023E462E0FQ35743960-44CD4FBF-92B4-4E32-853F-1A65FE12E523Q35766755-97BCFE3B-22BC-48F4-A118-FC5AC90DC94CQ35850620-C7F39B4B-B69B-43AF-B652-4CB57A87B537Q36028635-799506BB-E5C3-4066-B34D-131022ACC7DDQ36049267-81FDD1FE-F29C-4CE0-8E50-E6DF423671EFQ36136449-63A214A2-7497-4B63-8C78-E145A15FFBBEQ36228033-967026C3-7D1D-475B-90FA-804500D1849CQ36561514-6185B719-0BA9-47DC-9FE2-21E9AE0F5499Q37195612-128D8359-940B-42B1-AE9A-A8325DEBDE14Q37195735-5C331422-5957-41F5-AC13-204154B37793Q37612290-C0C46D99-B724-49EB-88A5-E362D3865175Q38275213-A9153FB2-6677-46E1-9A0A-3E7E17214354Q38419194-98748DBD-D836-4573-B6C7-ECDF73C658FEQ38430909-9446DE08-6FB4-4EA0-BBD5-52690893FF26Q38677715-39A6A442-DD37-44CD-AAB9-E4BCEFCFE07DQ38742769-BA56A6A1-C559-4831-BF57-D0CC987C7749Q38769993-9944D41C-21D2-4CEF-AEC2-3B40CF4D335AQ38806840-8526003F-400D-4CB5-AC89-B8D24FC67DC2Q38981604-9B07B5A6-10A4-4890-AAFC-8FB3543A9920Q39224276-2AFFC48C-F050-4497-81B0-1410D43A1D66
P2860
Dysbiosis contributes to fibrogenesis in the course of chronic liver injury in mice.
description
2014 nî lūn-bûn
@nan
2014 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Dysbiosis contributes to fibrogenesis in the course of chronic liver injury in mice.
@ast
Dysbiosis contributes to fibrogenesis in the course of chronic liver injury in mice.
@en
Dysbiosis contributes to fibrogenesis in the course of chronic liver injury in mice.
@nl
type
label
Dysbiosis contributes to fibrogenesis in the course of chronic liver injury in mice.
@ast
Dysbiosis contributes to fibrogenesis in the course of chronic liver injury in mice.
@en
Dysbiosis contributes to fibrogenesis in the course of chronic liver injury in mice.
@nl
prefLabel
Dysbiosis contributes to fibrogenesis in the course of chronic liver injury in mice.
@ast
Dysbiosis contributes to fibrogenesis in the course of chronic liver injury in mice.
@en
Dysbiosis contributes to fibrogenesis in the course of chronic liver injury in mice.
@nl
P2093
P356
P1433
P1476
Dysbiosis contributes to fibrogenesis in the course of chronic liver injury in mice.
@en
P2093
Antonio Benedetti
Bruna Facinelli
Chiara Rychlicki
Cinzia Candelaresi
Claudio Palmieri
Eleonora Mingarelli
Gianluca Svegliati-Baroni
Gloria Magi
Laura Agostinelli
Luciano Trozzi
P304
P356
10.1002/HEP.26695
P407
P577
2014-02-25T00:00:00Z